000282370 001__ 282370
000282370 005__ 20240918105537.0
000282370 0247_ $$2doi$$a10.2196/45198
000282370 0247_ $$2pmid$$apmid:37639311
000282370 0247_ $$2ISSN$$a1439-4456
000282370 0247_ $$2ISSN$$a1438-8871
000282370 0247_ $$2altmetric$$aaltmetric:153398885
000282370 037__ $$aDKFZ-2023-01752
000282370 041__ $$aEnglish
000282370 082__ $$a610
000282370 1001_ $$00000-0001-5067-0430$$aMemenga, Paula$$b0
000282370 245__ $$aIntentions of Patients With Cancer and Their Relatives to Use a Live Chat on Familial Cancer Risk: Results From a Cross-Sectional Web-Based Survey.
000282370 260__ $$aRichmond, Va.$$bHealthcare World$$c2023
000282370 3367_ $$2DRIVER$$aarticle
000282370 3367_ $$2DataCite$$aOutput Types/Journal article
000282370 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1726649717_8429
000282370 3367_ $$2BibTeX$$aARTICLE
000282370 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000282370 3367_ $$00$$2EndNote$$aJournal Article
000282370 500__ $$a#LA:M100#
000282370 520__ $$aAn important prerequisite for actively engaging in cancer prevention and early detection measures, which is particularly recommended in cases of familial cancer risk, is the acquisition of information. Although a lot of cancer information is available, not all social groups are equally well reached because information needs and communicative accessibility differ. Previous research has shown that a live chat service provided by health professionals could be an appropriate, low-threshold format to meet individual information needs on sensitive health topics such as familial cancer risk. An established German Cancer Information Service is currently developing such a live chat service. As it is only worthwhile if accepted by the target groups, formative evaluation is essential in the course of the chat service's development and implementation.This study aimed to explore the acceptance of a live chat on familial cancer risk by patients with cancer and their relatives (research question [RQ] 1) and examine the explanatory power of factors associated with their intentions to use such a service (RQ2). Guided by the Extended Unified Theory of Acceptance and Use of Technology (UTAUT2), we examined the explanatory power of the following UTAUT2 factors: performance expectancy, effort expectancy, social influence, facilitating conditions, and habit, supplemented by perceived information insufficiency, perceived susceptibility, perceived severity, and cancer diagnosis as additional factors related to information seeking about familial cancer.We conducted a cross-sectional survey via a German web-based access panel in March 2022 that was stratified by age, gender, and education (N=1084). The participants are or have been diagnosed with cancer themselves (n=144) or have relatives who are or have been affected (n=990). All constructs were measured with established scales. To answer RQ1, descriptive data (mean values and distribution) were used. For RQ2, a blockwise multiple linear regression analysis was conducted.Overall, 32.7% of participants were (rather) willing, 28.9% were undecided, and 38.4% were (rather) not willing to use a live chat on familial cancer risk in the future. A multiple linear regression analysis explained 47% of the variance. It revealed that performance expectancy, social influence, habit, perceived susceptibility, and perceived severity were positively associated with the intention to use a live chat on familial cancer risk. Effort expectancy, facilitating conditions, information insufficiency, and cancer diagnosis were not related to usage intentions.A live chat seems promising for providing information on familial cancer risk. When promoting the service, the personal benefits should be addressed in particular. UTAUT2 is an effective theoretical framework for explaining live chat usage intentions and does not need to be extended in the context of familial cancer risk.
000282370 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000282370 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000282370 650_7 $$2Other$$aExtended Unified Theory of Acceptance and Use of Technology
000282370 650_7 $$2Other$$acancer information seeking
000282370 650_7 $$2Other$$acancer risk
000282370 650_7 $$2Other$$across-sectional survey
000282370 650_7 $$2Other$$adiagnosis
000282370 650_7 $$2Other$$afamilial cancer risk
000282370 650_7 $$2Other$$agenetic testing
000282370 650_7 $$2Other$$alive chat
000282370 650_7 $$2Other$$apatients and relatives with cancer
000282370 650_7 $$2Other$$apatients with cancer
000282370 650_7 $$2Other$$aseverity
000282370 650_7 $$2Other$$atechnology acceptance
000282370 7001_ $$00000-0002-2357-2138$$aBaumann, Eva$$b1
000282370 7001_ $$00000-0002-3118-248X$$aLuetke Lanfer, Hanna$$b2
000282370 7001_ $$00000-0002-8961-7220$$aReifegerste, Doreen$$b3
000282370 7001_ $$0P:(DE-He78)753065f68c8fb4732728045fb653f044$$aGeulen, Julia$$b4$$udkfz
000282370 7001_ $$0P:(DE-He78)8eb7c034317c85ac16b491268dde93d7$$aWeber, Winja$$b5$$udkfz
000282370 7001_ $$00009-0009-9715-4957$$aHahne, Andrea$$b6
000282370 7001_ $$aMüller, Anne$$b7
000282370 7001_ $$0P:(DE-He78)76dcc66f81ef265e1968a39c42318846$$aWeg-Remers, Susanne$$b8$$eLast author$$udkfz
000282370 773__ $$0PERI:(DE-600)2028830-X$$a10.2196/45198$$gVol. 25, p. e45198 -$$pe45198$$tJournal of medical internet research$$v25$$x1439-4456$$y2023
000282370 909CO $$ooai:inrepo02.dkfz.de:282370$$pVDB
000282370 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)753065f68c8fb4732728045fb653f044$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000282370 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8eb7c034317c85ac16b491268dde93d7$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000282370 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)76dcc66f81ef265e1968a39c42318846$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000282370 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000282370 9141_ $$y2023
000282370 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-04-01T12:45:48Z
000282370 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-30
000282370 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-30
000282370 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-30
000282370 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-30
000282370 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000282370 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-24
000282370 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ MED INTERNET RES : 2022$$d2023-10-24
000282370 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000282370 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T14:53:43Z
000282370 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T14:53:43Z
000282370 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2023-04-12T14:53:43Z
000282370 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000282370 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000282370 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
000282370 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ MED INTERNET RES : 2022$$d2023-10-24
000282370 9202_ $$0I:(DE-He78)M100-20160331$$kM100$$lM100 Krebsinformationsdienst$$x0
000282370 9201_ $$0I:(DE-He78)M100-20160331$$kM100$$lM100 Krebsinformationsdienst$$x0
000282370 980__ $$ajournal
000282370 980__ $$aVDB
000282370 980__ $$aI:(DE-He78)M100-20160331
000282370 980__ $$aUNRESTRICTED